GlassScriptPhysician profile
Christian Gonzalez
NPI 1912987983
$44,710.39
in general payments reported to CMS, 2019-2025
58 companies · $9,922 in 2025
The $9,922 reported for 2025 was more than what 95% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $2,096 · 2021: $6,683 · 2022: $5,408 · 2023: $4,335 · 2024: $5,669 · 2025: $9,922.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $20K.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $19,926.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $16,330.85 | 2019-2025 | Proclaim, Eterna |
| Biotronik Nro, INC. | $11,697.90 | 2023-2025 | Prospera, Biotronik |
| Vertos Medical, INC. | $2,567.68 | 2019-2024 | Mild Device Kit |
| Medtronic, INC. | $2,344.92 | 2021-2025 | Intellis Adaptivestim, Kyphon Express II Kyphopak Tray, Synchromedii |
| Spinal Simplicity, LLC | $2,224.39 | 2021-2025 | Ha Minuteman G3-R |
| Vertiflex, INC. | $1,733.18 | 2019 | |
| Scilex Pharmaceuticals INC. | $975.80 | 2019-2025 | Ztlido |
| Boston Scientific Corporation | $823.71 | 2020-2025 | Intracept, Superion Indirect Decompression System, General - Pain Management |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $737.71 | 2021-2025 | Relistor |
| Spr Therapeutics, INC | $565.86 | 2022-2025 | Sprint Pns System |
| Redhill Biopharma INC. | $424.21 | 2020-2023 | Aemcolo, Movantik, Talicia |
| Protega Pharmaceutials INC | $368.93 | 2025 | Roxybond |
| Forte Bio-Pharma LLC | $362.52 | 2020-2025 | Prolate, Nalocet, Tanlor |
| Collegium Pharmaceutical, INC. | $341.30 | 2019-2025 | Xtampza |
| Medtronic USA, INC. | $333.40 | 2019-2020 |
Show all 58 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christian Gonzalez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.